Furthermore, because of the critical role of the intratumoral immune cell infiltration level in disease progression and prognosis, we also investigated the potential correlation of GSE1 and TACSTD2 expression with the immune cell infiltration level in the TCGA PRAD cohort (n = 623). This evidence concerns the gene TACSTD2 and prostate adenocarcinoma.